These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 19554391)
1. The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma. Chuma M; Hige S; Kamiyama T; Meguro T; Nagasaka A; Nakanishi K; Yamamoto Y; Nakanishi M; Kohara T; Sho T; Yamamoto K; Horimoto H; Kobayashi T; Yokoo H; Matsushita M; Todo S; Asaka M J Gastroenterol; 2009; 44(9):991-9. PubMed ID: 19554391 [TBL] [Abstract][Full Text] [Related]
2. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy. Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297 [TBL] [Abstract][Full Text] [Related]
3. Association of Hepatitis B Virus DNA Level and Follow-up Interval With Hepatocellular Carcinoma Recurrence. Wang W; Tian SL; Wang H; Shao CC; Wang YZ; Li YL JAMA Netw Open; 2020 Apr; 3(4):e203707. PubMed ID: 32338753 [TBL] [Abstract][Full Text] [Related]
4. Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma. Urata Y; Kubo S; Takemura S; Uenishi T; Kodai S; Shinkawa H; Sakae M; Kaneda K; Ohata K; Nozawa A; Suehiro S J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):685-96. PubMed ID: 22203455 [TBL] [Abstract][Full Text] [Related]
5. Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative. Wang K; Jiang G; Jia Z; Zhu X; Ni C Medicine (Baltimore); 2018 Jun; 97(22):e10940. PubMed ID: 29851833 [TBL] [Abstract][Full Text] [Related]
6. Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma. Sohn W; Kang TW; Choi SK; Jung SH; Lee MW; Lim HK; Cho JY; Shim SG; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Rhim H; Paik YH Oncotarget; 2016 Jul; 7(30):47794-47807. PubMed ID: 27329596 [TBL] [Abstract][Full Text] [Related]
7. Antiviral Therapy Reduces Hepatocellular Carcinoma Recurrence in Patients With Low HBV-DNA Levels: A Randomized Controlled Trial. Huang G; Li PP; Lau WY; Pan ZY; Zhao LH; Wang ZG; Wang MC; Zhou WP Ann Surg; 2018 Dec; 268(6):943-954. PubMed ID: 29521740 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B viral load affects prognosis of hepatocellular carcinoma. Yu SJ; Kim YJ World J Gastroenterol; 2014 Sep; 20(34):12039-44. PubMed ID: 25232241 [TBL] [Abstract][Full Text] [Related]
9. Intermediate-stage hepatocellular carcinoma patients with a high HBV-DNA load may benefit from postoperative anti-hepatitis B virus therapy. Rui S; Yan J; Zhang H; Wang Z; Zhou W Medicine (Baltimore); 2017 Jul; 96(30):e7608. PubMed ID: 28746212 [TBL] [Abstract][Full Text] [Related]
10. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma. Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247 [TBL] [Abstract][Full Text] [Related]
11. HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy. Hosaka T; Suzuki F; Kobayashi M; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Akuta N; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H Liver Int; 2010 Nov; 30(10):1461-70. PubMed ID: 20840396 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. Kuzuya T; Katano Y; Kumada T; Toyoda H; Nakano I; Hirooka Y; Itoh A; Ishigami M; Hayashi K; Honda T; Goto H J Gastroenterol Hepatol; 2007 Nov; 22(11):1929-35. PubMed ID: 17914972 [TBL] [Abstract][Full Text] [Related]
13. A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib. Yang Y; Wen F; Li J; Zhang P; Yan W; Hao P; Xia F; Bi F; Li Q Liver Int; 2015 Sep; 35(9):2147-54. PubMed ID: 25676812 [TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation. Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269 [TBL] [Abstract][Full Text] [Related]
15. The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy. Su CW; Chiou YW; Tsai YH; Teng RD; Chau GY; Lei HJ; Hung HH; Huo TI; Wu JC PLoS One; 2013; 8(6):e66457. PubMed ID: 23805222 [TBL] [Abstract][Full Text] [Related]
16. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study. Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631 [TBL] [Abstract][Full Text] [Related]
17. High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection. Qu LS; Jin F; Huang XW; Shen XZ J Gastrointest Surg; 2010 Jul; 14(7):1111-20. PubMed ID: 20422305 [TBL] [Abstract][Full Text] [Related]
18. Perioperative antiviral therapy improves the prognosis of HBV DNA-negative patients with HBV-related hepatocellular carcinoma. Li C; Li ZC; Ma L; Li LQ; Zhong JH; Xiang BD; Gong WF Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):749-756. PubMed ID: 32552297 [TBL] [Abstract][Full Text] [Related]
19. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma. Huang L; Li J; Lau WY; Yan J; Zhou F; Liu C; Zhang X; Shen J; Wu M; Yan Y J Gastroenterol Hepatol; 2012 Jan; 27(1):158-64. PubMed ID: 21871026 [TBL] [Abstract][Full Text] [Related]
20. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma. Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]